JP2016529235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529235A5 JP2016529235A5 JP2016526992A JP2016526992A JP2016529235A5 JP 2016529235 A5 JP2016529235 A5 JP 2016529235A5 JP 2016526992 A JP2016526992 A JP 2016526992A JP 2016526992 A JP2016526992 A JP 2016526992A JP 2016529235 A5 JP2016529235 A5 JP 2016529235A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- amino
- group
- alkyl
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361846787P | 2013-07-16 | 2013-07-16 | |
| US61/846,787 | 2013-07-16 | ||
| PCT/US2014/046203 WO2015009545A1 (en) | 2013-07-16 | 2014-07-10 | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529235A JP2016529235A (ja) | 2016-09-23 |
| JP2016529235A5 true JP2016529235A5 (enExample) | 2017-08-17 |
| JP6653253B2 JP6653253B2 (ja) | 2020-02-26 |
Family
ID=51230227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526992A Expired - Fee Related JP6653253B2 (ja) | 2013-07-16 | 2014-07-10 | ホルミルペプチド受容体モジュレーターとしてのｎ−尿素置換アミノ酸の誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9428549B2 (enExample) |
| EP (1) | EP3022174B1 (enExample) |
| JP (1) | JP6653253B2 (enExample) |
| KR (1) | KR102313757B1 (enExample) |
| CN (1) | CN105377814B (enExample) |
| AU (1) | AU2014290618B2 (enExample) |
| CA (1) | CA2917811C (enExample) |
| DK (1) | DK3022174T3 (enExample) |
| ES (1) | ES2708571T3 (enExample) |
| RU (1) | RU2696581C2 (enExample) |
| WO (1) | WO2015009545A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX376348B (es) | 2011-10-26 | 2025-03-07 | Allergan Inc | Derivados de amida de aminoacidos sustituidos con n-urea como moduladores de receptor de tipo peptido receptor de formilo-1 (fprl-1). |
| CA2899804A1 (en) | 2013-03-06 | 2014-09-12 | Allergan, Inc. | Use of agonists of formyl peptide receptor 2 for treating dermatological diseases |
| EP3071548B1 (en) | 2013-11-21 | 2017-11-08 | Allergan, Inc. | Phenylcarbamate derivatives as formyl peptide receptor modulators |
| SMT201800061T1 (it) | 2013-11-28 | 2018-05-02 | Kyorin Seiyaku Kk | Derivati dell'urea o loro sali farmacologicamente accettabili utili come io agonisti del recettore del peptide formile di tipo i (fprl-1) |
| US9663457B2 (en) | 2014-04-09 | 2017-05-30 | Allergan, Inc. | Carbamoyl hydrazine derivatives as formyl peptide modulators |
| CN106458921B (zh) | 2014-05-21 | 2020-03-24 | 阿勒根公司 | 作为甲酰肽受体调节剂的咪唑衍生物 |
| CN107848962B (zh) | 2015-05-27 | 2021-04-09 | 杏林制药株式会社 | 脲衍生物或其药理学上可接受的盐 |
| ES2814126T3 (es) | 2015-05-27 | 2021-03-26 | Kyorin Seiyaku Kk | Derivado de urea o sal farmacológicamente aceptable del mismo |
| TW201718473A (zh) * | 2015-08-05 | 2017-06-01 | 歐樂根公司 | 作為甲醯肽受體１（ｆｐｒ１）選擇性促效劑之苯基脲類似物 |
| EP3762380B1 (en) | 2018-03-05 | 2021-12-15 | Bristol-Myers Squibb Company | Phenylpyrrolidinone formyl peptide 2 receptor agonists |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2533210A1 (fr) * | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | Edulcorants de synthese |
| US5284828A (en) | 1990-05-14 | 1994-02-08 | Fujisawa Pharmaceutical Co. Ltd. | Peptide compound and its preparation |
| JP3387948B2 (ja) | 1992-12-04 | 2003-03-17 | 富山化学工業株式会社 | 新規なフェニルアラニン誘導体またはその塩 |
| US20030009022A1 (en) * | 1993-03-31 | 2003-01-09 | Cadus Pharmaceutical Corporation | Methods and compositions for identifying receptor effectors |
| BR9506763A (pt) * | 1994-02-09 | 1997-10-07 | Shionogi & Co | Derivados de carbamoil metil uréia |
| JP2968842B2 (ja) * | 1994-02-09 | 1999-11-02 | 塩野義製薬株式会社 | カルバモイルメチルウレア誘導体 |
| US6423689B1 (en) * | 1997-12-22 | 2002-07-23 | Warner-Lambert Company | Peptidyl calcium channel blockers |
| WO1999065932A1 (en) | 1998-06-18 | 1999-12-23 | Sepracor, Inc. | Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors |
| EP1492552A2 (en) * | 2002-04-03 | 2005-01-05 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| EP1692502A2 (en) * | 2003-11-07 | 2006-08-23 | Acadia Pharmaceuticals Inc. | Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
| CN102414168B (zh) * | 2009-05-18 | 2014-05-21 | 埃科特莱茵药品有限公司 | 用作为alx受体和/或fprl2激动剂的桥联螺[2.4]庚烷衍生物 |
| AU2011336973A1 (en) * | 2010-12-03 | 2013-07-11 | Allergan, Inc. | Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| MX376348B (es) * | 2011-10-26 | 2025-03-07 | Allergan Inc | Derivados de amida de aminoacidos sustituidos con n-urea como moduladores de receptor de tipo peptido receptor de formilo-1 (fprl-1). |
| US8541577B2 (en) * | 2011-11-10 | 2013-09-24 | Allergan, Inc. | Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators |
| US8735622B2 (en) * | 2011-11-30 | 2014-05-27 | The Regents Of The University Of Colorado, A Body Corporate | Histone demethylase inhibitors and methods for using the same |
| CA2899804A1 (en) * | 2013-03-06 | 2014-09-12 | Allergan, Inc. | Use of agonists of formyl peptide receptor 2 for treating dermatological diseases |
| AU2014225992B2 (en) * | 2013-03-06 | 2018-03-22 | Allergan, Inc. | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
-
2014
- 2014-07-10 ES ES14744725T patent/ES2708571T3/es active Active
- 2014-07-10 CA CA2917811A patent/CA2917811C/en active Active
- 2014-07-10 US US14/328,540 patent/US9428549B2/en active Active
- 2014-07-10 AU AU2014290618A patent/AU2014290618B2/en not_active Ceased
- 2014-07-10 CN CN201480040132.5A patent/CN105377814B/zh not_active Expired - Fee Related
- 2014-07-10 WO PCT/US2014/046203 patent/WO2015009545A1/en not_active Ceased
- 2014-07-10 JP JP2016526992A patent/JP6653253B2/ja not_active Expired - Fee Related
- 2014-07-10 EP EP14744725.4A patent/EP3022174B1/en active Active
- 2014-07-10 DK DK14744725.4T patent/DK3022174T3/da active
- 2014-07-10 KR KR1020167003770A patent/KR102313757B1/ko not_active Expired - Fee Related
- 2014-07-10 RU RU2016104844A patent/RU2696581C2/ru active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016529235A5 (enExample) | ||
| JP2017537940A5 (enExample) | ||
| RU2016104844A (ru) | Производные n-мочевино замещенных аминокислот как модуляторы формил-пептидного рецептора | |
| JP2016530310A5 (enExample) | ||
| JP2019514874A5 (enExample) | ||
| JP2016536364A5 (enExample) | ||
| JP2016536363A5 (enExample) | ||
| JP2015537020A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| JP2016503797A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| RU2012125372A (ru) | Производные пиразола в качестве ингибиторов 11-бета-hsd1 | |
| JP2014502979A5 (enExample) | ||
| JP2017517538A5 (enExample) | ||
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| JP2012513416A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2016531126A5 (enExample) | ||
| JP2015535847A5 (enExample) | ||
| JP2018048143A5 (enExample) | ||
| EA201270359A1 (ru) | Терапевтическое средство от расстройств настроения | |
| RU2016151420A (ru) | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий | |
| JP2016528273A5 (enExample) | ||
| JP2019535723A5 (enExample) | ||
| JP2004525183A5 (enExample) |